Published: Thursday, August 15, 2024 · 1:06 AM | Updated: Thursday, August 15, 2024 · 1:06 AM
📊 501 views
Aug 13, 2024 / 08:30PM GMT
Operator
Good day, and welcome to the NovaBay Pharmaceuticals second-quarter 2024 financial results conference call. (Operator Instructions) Please note, this event is being recorded.
I would now like to turn the conference over to Jody Cain, please go ahead.
Jody Cain – LHA Investor Relations – Analyst
This is Jody Cain with LHA. Thank you for participating in today’s call. Joining me from NovaBay Pharmaceuticals are Justin Hall, Executive Officer and General Counsel; and Tommy Law, Interim Chief Financial Officer.
I’d like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of federal securities laws. These forward-looking statements involve risks and uncertainties that could cause actual results to be materially different from any anticipated results. In particular, there is uncertainty about circumstances beyond the company’s control that impact the broader economy. This means that results could change at any time and the contemplated impact of such circumstances on
MORE IN INSIDE INVESTMENT NEWS
ASML’s Decade-Long Demand: Alpha Opportunity in Chip Manufacturing
Published: Wednesday, October 14, 2026 · 2:45 AM
Goldman Sachs Rating Upgrade: Alpha Potential After Strong Q3 Performance
Published: Tuesday, October 13, 2026 · 3:58 PM
